| Scientific Name |
Pegcetacoplan
|
|---|---|
| Brand Name |
Empaveli
|
| Risk |
Risk of: 1. serious infection due to encapsulated bacteria 2. Serious hypersensitivity reactions 3. Risk of potential long-term effects of Polyethylene Glycol (PEG) accumulation 4. Risk of intravascular haemolysis after discontinuation and postponement of administration of the medicinal product (PNH indication only) 5.And to include recently Saudi approved indication C3G indication for Pegcetacoplan on updated aRMMs.
|
| Educational Materials for Healthcare Professionals |
|
| Educational Materials for Patients |
|
Pegcetacoplan
Pegcetacoplan
